Mediastinal Mesothelioma in a Bitch - Removal with Median sternotomy

Authors

DOI:

https://doi.org/10.22456/1679-9216.129954

Keywords:

Cirurgia, Tórax, Toracotomia, Neoplasia, Mesotelioma

Abstract

Background: Malignant pleural mesothelioma (MPM) is a neoplasm with low incidence in small animals, and the possible causes are poorly elucidated but may be related to contact with asbestos. In the thoracic cavity, MMP can be localized or generalized to all cavity structures, and its clinical signs depend on this localization. Although some alternative therapies are being discussed, few studies are conclusive, with surgical intervention as the leading therapeutic option. Given this context, this report aimed to describe a case of MMP located in the mediastinum of a bitch treated with radical excision through mediated sternotomy.

Case: A 7-year-old bitch of the Shar-pei breed was referred for care due to progressive weight loss and intense dyspnea. During the physical examination, dyspnea and muffled lung sounds were noted. The patient underwent hemodialysis, which showed neutrophilic leukocytosis. An abdominal ultrasound was also performed and revealed mild abdominal effusion, and chest radiography revealed an extensive tumor covering the entire chest cavity. Thoracocentesis was performed, and the material analyzed was a malignant exudate; the patient was referred to median sternotomy for exploratory purposes, and afterward, total macroscopic extirpation of the tumor was performed. A sample was sent for histopathology, and malignant mesothelioma was confirmed. The patient was discharged after 8 days of hospitalization with home treatment and did not return to the hospital. Upon contacting the guardian, we were informed that the animal had died 154 days after the procedure due to unknown causes.

Discussion: Malignant pleural mesothelioma affects humans and animals; it is associated with the risk factor of contact with asbestos and the use of flea antiparasitic drugs. In small animals, its incidence is rare, albeit mesotheliomas have been reported in wild and large animals. The clinical signs are related to the location of the neoplasm. When it is located in the thoracic region, dyspnea, muffled lung sounds, cyanosis, and pleural effusion are observed in most cases. Diagnosis is usually late and incidental, although some tests, such as ultrasonography, magnetic resonance imaging, tomography, radiography, and needle biopsy, can help in the diagnosis. Histopathology is the exam of choice for definitive diagnosis, as it helps one observe the proliferation of neoplastic mesothelial cells, atypical mitosis figures, and marked cellular pleomorphism. Many therapeutic options have been discussed, including chemotherapy, immunotherapy, and anti-tumor immunization, although there is little scientific proof of their efficacy in animals. The current treatment of choice is tumor excision by surgical procedure with a palliative objective since the prognosis of the disease is unfavorable. Minimally invasive video surgery has been gaining more and more space in veterinary medicine and has proven successful in numerous cases of thoracic masses. In the present report, we chose to perform median sternotomy for total excision due to the extension of the mass that occupied the thoracic cavity practically in its entirety. Further research should be conducted to help in palliative treatments and increase the survival of patients with mesotheliomas, given that most studies are done in humans and not animals. We conclude that median sternotomy is still the therapeutic option of choice for the palliative treatment of patients with extensive thoracic pleural mesotheliomas.

Keywords: canine, surgery, thorax, thoracotomy, neoplasm, mesothelioma.

Título: Mesotelioma pleural em mediastino em uma cadela - remoção com esternotomia mediana

Descritores: canino, cirurgia, tórax, toracotomia, neoplasma, mesotelioma.

 

Downloads

Download data is not yet available.

References

Aigner C., Brüning T., Eberhardt W.E.E., Härter M., Kaelbarlah H.P., Metzenmacher M., Shah R., Taube C. & Thomas M. 2021. Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier. Pneumologie. 5(10): 776-794. DOI: 10.1055/a-1404-1562. DOI: https://doi.org/10.1055/a-1404-1562

Bacci B., Morandi F., De Meo M. & Marcato P. S. 2006. Ten Cases of Feline Mesothelioma: an Immunohistochemical and Ultrastructural Study. Journal of Comparative Pathology. 134(4): 347-354. DOI: 10.1016/J.JCPA.2006.02.001. DOI: https://doi.org/10.1016/j.jcpa.2006.02.001

D'Angelo A.R., Francesco G., Di Quaglione G.R. & Marruchella G. 2014. Sclerosing peritoneal mesothelioma in a dog: histopathological, histochemical and immunohistochemical investigations. Veterinary Italy. 50(4): 301-305. DOI: 10.12834/VetIt.20.1309.130.

Davis A.P., Kao S.C., Clarke S.J., Boyer M. & Pavlakis N. 2021. Emerging biological therapies for the treatment of malignant pleural mesothelioma. Expert Opinion on Emerging Drugs. 26(2): 179-192. DOI: 10.1080/14728214.2021.1924670. DOI: https://doi.org/10.1080/14728214.2021.1924670

Fasola G., Puglisi F., Follador A., Aita M., Di Terlizzi S. & Belvedere. 2006. Dramatic tumour response to pemetrexed single-agent in and elderly patient with malignant peritoneal mesothelioma: a case report. BMC Cancer. 18(6): 289. DOI: 10.1186/1471-2407-6-289. DOI: https://doi.org/10.1186/1471-2407-6-289

Glickman L.T., Domanski L.M., Maguire T.G., Dubielzig R.R. & Churg A. 1983. Mesothelioma in pet dogs associated with exposure of their owners to asbestos. Environmental research. 32(2): 305. DOI: 10.1016/0013-93518390114-7. DOI: https://doi.org/10.1016/0013-9351(83)90114-7

Henrich K., Giacomolli C., Pesamosca N.M., Bergoli R., Gnoatto F.W., Luz M., Rossato C.K., Palma H. & Bassuino D.M. 2017. Mesotelioma pleural maligno misto em canino – relato de caso. In: Resumos dos Anais do XXII Seminário interinstitucional de ensino, pesquisa e extensão rede e territórios (Cruz Alta, Brazil).

MacDonald K.A., Cagney O. & Magne M.L. 2009. Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985-2006). Journal of American Veterinary Medical Association. 235(12): 1456-1461. DOI: 10.2460/javma.235.12.1456. DOI: https://doi.org/10.2460/javma.235.12.1456

Manzini V.P., Recchia L., Cafferata M., Porta C., Siena S., Giannetta L., Morelli F., Oniga F., Bearz A., Torri V. & Cinquini M. 2010. Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Annals of Oncology. 21(2): 348. DOI: 10.1093/annonc/mdp307. DOI: https://doi.org/10.1093/annonc/mdp307

Metro G., Signorelli D., Pizzutilo E.G., Giannetta L., Cerea G., Garaffa M., Friedlaender A., Addeo A., Mandarano M., Bellezza G. & Roila F. 2021. Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma. Human Vaccines & Immunotherapeutics. 17(9): 2972-2980. DOI: 10.1080/21645515.2021.1917933. DOI: https://doi.org/10.1080/21645515.2021.1917933

Mezzapelle R., De Marchis F., Passera C., Leo M., Brambilla F., Colombo F., Casalgrandi M., Preti A., Zambrano S., Castellani P., Ertassi R., Silingardi M., Caprioglio F., Basso V., Boldorini R., Carretta A., Sanvito F., Rena O., Rubartelli A., Sabatino L., Mondino A., Crippa M.P., Colantuoni V. & Bianchi M.E. 2021. CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma. EMBO Molecular Medicine. 13(6): e12344. DOI: 10.15252/emmm.202012344. DOI: https://doi.org/10.15252/emmm.202012344

Morita Y., Sugiyama S., Tsuka T., Okamoto Y., Morita T., Sunden Y. & Takeuchi T. 2019. Diagnostic efficacy of imaging and biopsy methods for peritoneal mesothelioma in a calf. BMC Veterinary Reserch. 15(1): 461. DOI: 10.1186/s12917-019-2195. DOI: https://doi.org/10.1186/s12917-019-2195-z

Nabeta R., Nakagawa Y., Chiba S., Xiantao H., Usui T., Suzuki K., Furuya T., Fukushima R. & Uchide T. 2019. Pericardial Mesothelioma in a Dog: The Feasibility of Ultrasonography in Monitoring Tumor Progression. Frontiers in Veterinary Science. 18(6): 121. DOI: 10.3389/fvets.2019.00121. DOI: https://doi.org/10.3389/fvets.2019.00121

Palma M., De-León J. & Arreola J. 2021. Malignant Pleural Mesothelioma. Revista médica (Colégio de Médicos y Cirujanos da Guatemala). 160(1): 94-96. DOI: 10.36109/rmg.v160i1.245. DOI: https://doi.org/10.36109/rmg.v160i1.245

Piacenti A.M., Ocarino N.M., Silva A.E., Rachid M.A., França S.A. & Serakides R. 2004. Mesotelioma pleural com metástase renal em gato. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 56(4): 558-561. DOI: 10.1590/S0102-09352004000400021. DOI: https://doi.org/10.1590/S0102-09352004000400021

McGavin M.D. & Zachary J.F. 2013. Sistema Respiratório, Mediastino e Pleuras. In: Brown D.L., Van Wettere A.J. & Cullen J.M. (Eds). Bases da Patologia em Veterinária. 5.ed. São Paulo: Elsevier Editora Ltda., pp.540-541.

Additional Files

Published

2023-08-08

How to Cite

Konrad Nava Calva, C., Vitória Hörbe, A., Santiago Ventura de Aguiar, E., Felix Leão Neto , L., Eula Marques, L., Yumi Miyaguni Morais, C., Cristina dos Santos , V., & Scussel Feranti , J. P. (2023). Mediastinal Mesothelioma in a Bitch - Removal with Median sternotomy. Acta Scientiae Veterinariae, 51. https://doi.org/10.22456/1679-9216.129954